Updated

Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug. The drug has been championed by veterans, conservative lawmakers and podcasters aligned with President Trump. PBS NewsHour reported the announcement, which targets research into treatment for post-traumatic stress disorder.